Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10698232rdf:typepubmed:Citationlld:pubmed
pubmed-article:10698232lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C0031001lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C0021308lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C0012963lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C1366036lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C0040399lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C2350394lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:10698232lifeskim:mentionsumls-concept:C0044870lld:lifeskim
pubmed-article:10698232pubmed:issue1lld:pubmed
pubmed-article:10698232pubmed:dateCreated2000-3-16lld:pubmed
pubmed-article:10698232pubmed:abstractTextTetrofosmin gated single photon emission computed tomography (SPECT) allows simultaneous assessment of regional myocardial perfusion, global and regional left ventricular function, and function at rest and during pharmacologic intervention. SPECT with fatty acid analogues, such as beta-methyl-iodophenyl-pentadecanoic acid (BMIPP), can be used to monitor metabolic changes induced by myocardial ischemia. In this work, the results of both studies obtained in patients with recent myocardial infarction are integrated.lld:pubmed
pubmed-article:10698232pubmed:languageenglld:pubmed
pubmed-article:10698232pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:citationSubsetIMlld:pubmed
pubmed-article:10698232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10698232pubmed:statusMEDLINElld:pubmed
pubmed-article:10698232pubmed:issn1071-3581lld:pubmed
pubmed-article:10698232pubmed:authorpubmed-author:FrankenP RPRlld:pubmed
pubmed-article:10698232pubmed:authorpubmed-author:VanhoveCClld:pubmed
pubmed-article:10698232pubmed:authorpubmed-author:EveraertHHlld:pubmed
pubmed-article:10698232pubmed:issnTypePrintlld:pubmed
pubmed-article:10698232pubmed:volume7lld:pubmed
pubmed-article:10698232pubmed:ownerNLMlld:pubmed
pubmed-article:10698232pubmed:authorsCompleteYlld:pubmed
pubmed-article:10698232pubmed:pagination29-36lld:pubmed
pubmed-article:10698232pubmed:dateRevised2006-5-6lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:meshHeadingpubmed-meshheading:10698232...lld:pubmed
pubmed-article:10698232pubmed:articleTitleAssessment of perfusion, function, and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging.lld:pubmed
pubmed-article:10698232pubmed:affiliationDivision of Nuclear Medicine, University Hospital, Free University of Brussels, Belgium. nucgeth@az.vub.ac.belld:pubmed
pubmed-article:10698232pubmed:publicationTypeJournal Articlelld:pubmed